At the EU/EEA level, influenza activity continues to increase while RSV activity is decreasing. Vaccination campaigns against respiratory pathogens continue in many EU/EEA countries and people who are eligible for vaccination, particularly those at higher risk of severe outcomes, are encouraged to get vaccinated.